New Products
VARCLIN (Varenicline as tartarate) 0.5 - 1 mg
VARCLIN is a non-nicotine prescription medicine specifically developed to help adults 18 and over quit smoking.
- Home
- » New center
News
ALPHA - Boehringer Ingelheim was a Main Sponsor in the Annual ER Conference in Damascus, Syria
28 May 2010
ALPHA - Boehringer Ingelheim acted as one of the main sponsors in the 2010 Annual ER Conference that was held in Damascus, Sahara Center on May 28.
ORBIS Welcomes Syrian President Aboard Flying Eye Hospital
30 June 2008
Visit by His Excellency, the President Dr. Bashar al-Assad, raises awareness about blindness prevention in the Middle East...
15 September 2008
ALPHA held a conference in Sheraton Hotel in Aleppo on August 14th, 2008.
5 December 2007
ALPHA, Syria\'s leading pharmaceutical company, signed a scientific agreement with the University of Aleppo for sponsoring and funding scientific research in the field of Cancer treatment in collaboration with The Faculty of Pharmacy and a University in P